Beam Therapeutics Inc. · NASDAQ:BEAM

Dapice Joshua J. reported a 9.99% stake in Beam Therapeutics Inc. (Schedule 13G/A)

Event Mar 31, 2025 · Filed May 13, 2025

Dapice Joshua J. reported a 9.99% stake in Beam Therapeutics Inc., 9,972,980 shares, as a passive investor on Mar 31, 2025. Filed May 13, 2025 (Schedule 13G/A).

Stake
9.99%
Shares
9,972,980
Intent
Passive
What changed
Stake changed
Filed together
30 holders

The filing in full

HolderStakeShares
Farallon Capital Partners, L.P.0.70%708,049
Farallon Capital Institutional Partners, L.P.0.90%864,017
Farallon Capital Institutional Partners II, L.P.0.20%240,471
Farallon Capital Institutional Partners III, L.P.0.10%106,612
Four Crossings Institutional Partners V, L.P.0.20%154,093
Farallon Capital Offshore Investors II, L.P.1.70%1,683,455
Farallon Capital (AM) Investors, L.P.0.10%97,184
Farallon Capital F5 Master I, L.P.0.30%346,677
Farallon Healthcare Partners Master, L.P.5.80%5,772,422
Farallon Partners, L.L.C.9.60%9,626,303
Farallon Institutional (GP) V, L.L.C.0.20%154,093
Farallon F5 (GP), L.L.C.0.30%346,677
Farallon Healthcare Partners (GP), L.L.C.5.80%5,772,422
Dapice Joshua J.9.99%9,972,980
Dreyfuss, Philip D.9.99%9,972,980
Dunn Hannah E.9.99%9,972,980
Fried, Richard B9.99%9,972,980
Gehani, Varun N.9.99%9,972,980
Giauque, Nicolas9.99%9,972,980
Kim, David T.9.99%9,972,980
Linn, Michael G.9.99%9,972,980
Luo Patrick (Cheng)9.99%9,972,980
Patel, Rajiv A.9.99%9,972,980
Roberts, Jr., Thomas G.9.99%9,972,980
Saito Edric C.9.99%9,972,980
Seybold, William9.99%9,972,980
Short Daniel S.9.99%9,972,980
Spokes, Andrew J. M.9.99%9,972,980
Warren, John R.9.99%9,972,980
Wehrly, Mark C.9.99%9,972,980

Source

View original at SEC

Related